SYM FINANCIAL Corp Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

SYM FINANCIAL Corp lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 501 shares of the healthcare conglomerate’s stock after selling 78 shares during the period. SYM FINANCIAL Corp’s holdings in UnitedHealth Group were worth $248,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in UNH. GUNN & Co INVESTMENT MANAGEMENT INC. bought a new stake in UnitedHealth Group in the third quarter worth $3,426,000. Invst LLC increased its stake in UnitedHealth Group by 2.9% during the third quarter. Invst LLC now owns 1,252 shares of the healthcare conglomerate’s stock worth $631,000 after acquiring an additional 35 shares during the last quarter. Dakota Community Bank & Trust NA raised its holdings in UnitedHealth Group by 7.1% during the 3rd quarter. Dakota Community Bank & Trust NA now owns 332 shares of the healthcare conglomerate’s stock valued at $167,000 after buying an additional 22 shares during the period. Quantum Financial Advisors LLC increased its position in UnitedHealth Group by 10.4% during the third quarter. Quantum Financial Advisors LLC now owns 1,688 shares of the healthcare conglomerate’s stock valued at $851,000 after acquiring an additional 159 shares during the last quarter. Finally, Modera Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 4.3% in the 3rd quarter. Modera Wealth Management LLC now owns 39,737 shares of the healthcare conglomerate’s stock worth $20,035,000 after acquiring an additional 1,646 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price for the company in a research note on Wednesday, June 5th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Tuesday. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $581.44.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $7.00 during trading hours on Friday, reaching $511.36. The company had a trading volume of 1,340,786 shares, compared to its average volume of 4,220,115. The business’s 50 day moving average price is $499.20 and its 200-day moving average price is $500.05. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm has a market cap of $470.65 billion, a PE ratio of 30.93, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend was Monday, June 17th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.